Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Berne Stock Exchange  >  Vifor Pharma       

VIFOR PHARMA
Mes dernières consult.
Most popular
Report
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and markets pharmaceutical products and provides logistical & database services

Vifor Pharma AG, formerly Galenica AG, is a global specialty pharmaceuticals company.

It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies.

The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions.

Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives.

The company develops, manufactures and markets pharmaceutical products for precision patient care.

Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma.

The company was founded in 1927 and is headquartered in Bern, Switzerland.
Managers
NameAgeSinceTitle
Gianni Zampieri, PhD612002Chief Executive Officer & Director
Stefan Schulze512017President & Chief Operating Officer
Etienne Jornod641981Executive Chairman
Colin Bond, MBA562016Chief Financial Officer
Stefan Wohlfeil, MD-2012Chief Medical Officer
Daniela Bosshardt-Hengartner452008Non-Executive Director
Michel Burnier, MD642010Non-Executive Director
Fritz Hirsbrunner681977Non-Executive Director
Sylvie Louise Grégoire, PhD562013Non-Executive Director
Marc M. P. de Garidel EMBA592015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 65,000,000 46,012,840 70.8% 229,660 0.4% 70.8%
Shareholders
NameEquities%
Patinex AG 13,250,000 20.4%
Kodiak Invest AG 5,507,500 8.47%
Alecta Pension Insurance Mutual 2,100,000 3.23%
Sprint Acquisitions Holdings Ltd. 1,943,500 2.99%
Norges Bank Investment Management 1,862,330 2.87%
Amundi Asset Management SA (Investment Management) 1,551,528 2.39%
The Vanguard Group, Inc. 1,253,843 1.93%
Vontobel Asset Management AG 960,990 1.48%
Carmignac Gestion SA 866,347 1.33%
Oddo BHF Asset Management SAS 819,009 1.26%
Holdings
NameEquities%Valuation
Akebia Therapeutics Inc (AKBA) 3,571,4297.58%64,821,436 USD
Galenica AG (GALE) 1,250,0002.50%58,123,488 USD
Vifor Pharma (VIFN) 233,3300.36%30,032,343 USD
ChemoCentryx Inc (CCXI) 3,333,3336.84%21,899,998 USD
Company contact information
Vifor Pharma AG
Untermattweg 8
Bern, Bern (Berne) 3027

Phone : +41.58.852.81.11
Fax : +41.58.852.81.12
Web : www.viforpharma.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
VIFOR PHARMA8 390
JOHNSON & JOHNSON20.08%368 832
NOVARTIS12.75%219 874
ROCHE HOLDING LTD.4.90%215 394
PFIZER9.42%211 188
MERCK AND COMPANY-7.64%148 286
AMGEN16.16%123 376
SANOFI-0.25%114 646
BAYER9.45%106 161
NOVO NORDISK A/S29.01%102 274
BRISTOL-MYERS SQUIBB COMPANY4.79%100 068
ABBOTT LABORATORIES45.27%97 126
ELI LILLY AND COMPANY13.54%92 140
GLAXOSMITHKLINE-16.61%85 349
ASTRAZENECA12.83%83 904
CELGENE CORPORATION-9.72%82 794
ALLERGAN PLC-18.73%58 146
SHIRE-19.90%45 128
TAKEDA PHARMACEUTICAL CO LTD27.30%43 754
JIANGSU HENGRUI MEDICINE CO LTD52.11%29 368
CHUGAI PHARMACEUTICAL CO LTD67.51%28 271
Connections : Vifor Pharma
IVF HARTMANN AG
PX Therapeutics SA
Relypsa, Inc.
European ScreeningPort GmbH
Alliance Boots Ltd.
Neue Zürcher Zeitung AG
Metriopharm AG
VenCap 6 Ltd.
Royal Pharmaceutical Society of Great Britain
Mutuelle Vaudoise Société Coopérative
Aktiengesellschaft Für Die Neue Zürcher Zeitung
ESSEC Business School
Shire Orphan Therapies GmbH
Ipsen Pharma SAS
Vifor-Fresenius Medical Care Renal Pharma Ltd.
Corvidia Corp.
Vifor (International) AG
Nobel Biocare Holding AG
EIP Pharma LLC
Verve Capital Partners AG
European Research Council
European Federation of Pharmaceutical Industries & Assns
European Society of Hypertension
Société Des Membres De La Légion D'Honneur
Speedel Pharma AG
The Innovative Medicines Initiative
Centre Hospitalier Universitaire Vaudois
ESCP Europe Campus Paris
© 2017 People , Fundamentals and Ownership